Table 3.
In vitro interactions of administered antibacterials by time-kill methods against blood Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae isolates of 19 critically-ill patients.
Patient no | MEM+TIG † | MEM+GEN† | TIG+GEN† | MEM+TIG+GEN† | MEM+TIG+GEN†† | |||||
---|---|---|---|---|---|---|---|---|---|---|
1 | I | −0,17 | I | 0,64* | I | 0,13 | I | 0,91 | I | 0,27 |
2 | I | 0,38 | I | 0,14* | I | 1,3* | I | 1,5 | I | 0,20 |
3 | I | 0,26 | I | 0,31 | I | 0,07 | I | 1,02 | I | 0,71 |
4 | I | 0,42 | I | 0,41 | I | 0,23 | I | 1,03 | I | 0,62 |
5 | I | 0,41 | I | 0,78 | I | 0,36 | I | 1,39 | I | 1,11 |
6 | I | −0,10 | I | 0,54 | I | 0,10 | I | 0,63 | I | 0,09* |
7 | I | 0,39 | I | 0,42 | I | 0,35 | I | 0,84 | I | 0,42 |
8 | I | 1,07 | I | 0,32 | I | 0,25 | I | 0,54 | I | 0,22 |
9 | I | 0,59 | I | 0,43 | I | 0,64 | I | 1,13 | I | 0,49 |
10 | I | 0,59 | I | 0,63 | I | 0,43 | I | 1,25 | I | 0,62 |
11 | I | −0,24* | I | 0,30 | I | 0,07* | I | 0,36 | I | 0,06* |
12 | I | 1,80 | I | 0,70 | I | 0,48 | I | 1,02 | I | 0,32 |
13 |
I |
0,91 |
I |
0,43 |
I |
0,3 |
I |
0,73 |
I |
0,3 |
Patient no |
MEM+TIG† |
MEM+COL† |
TIG+COL† |
MEM+TIG+COL† |
MEM+TIG+COL†† |
|||||
14 | I | 0,9 | I | 0,44 | I | 1,33 | I | 1,84 | I | −0,49* |
15 | I | 0,16 | I | 0,45 | I | 0,50 | I | 1,31 | I | 0,81 |
16 | I | −0,24 | I | 0,25 | I | 0,35 | I | 1,11 | I | 0,76 |
17 | I | 0,27 | I | 1,23 | I | 1,07 | I | 1,45 | I | 0,22 |
18 | I | 0,15 | I | 0,18 | I | 0,30 | I | 0,42 | I | 0,24 |
19 | I | 0,14 | I | 0,07* | I | 0,26 | I | 0,94 | I | 0,68 |
Notes. Values are reported as mean Δlog; I, indifferent interaction.
Non statistically significant Δlog (p ≥ 0.05).
Δlog was calculated comparing the 2-drug or the 3-drug combination with the most effective single agent.
Δlog was calculated comparing the triple combination with the most effective double-antibiotic concentration.